Home
UroGen Pharma URGN paid BGR Government Affairs $60K for lobbying in Q4 2022 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2022
- Stock
- UroGen Pharma URGN
- Client
- Urogen Pharma
- Reported
- 23/01/20
$60K on lobbying in 2022
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Urogen Pharma's other lobbying reports
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 07/20
for Q2
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 04/20
for Q1
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 01/20
for Q4 2025
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 25/10/20
for Q3 2025
- Urogen Pharma
LobbyingUroGen Pharma
LobbyingUroGen Pharma
URGN
$30K
$30K
Reported 25/07/21
for Q2 2025